Evidence map›Paper›PMID 36406115›Full record

ArticleFrontiers in genetics2022

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators.

Dan Pu, Dan Liu, Can Li, Chunyan Chen, Yuxin Che, Jiaoyan Lv, Yang Yang, Xuelian Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dan PuDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Dan LiuDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Can LiDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Chunyan ChenDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yuxin CheDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Jiaoyan LvDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yang YangDepartment of Medical Basic Experimental Teaching Center, China Medical University, Shenyang, China.
Xuelian WangDepartment of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of immune-related prognostic biomarkers opens up the possibility of developing new immunotherapy strategies against tumors. In this study, we investigated immune-related biomarkers in the tumor microenvironment to predict the prognosis of cervical cancer (CC) patients. ESTIMATE and CIBERSORT algorithms were used to calculate the abundance of tumor-infiltrating immune cells (TICs) and the amount of immune and stromal components in cervical samples (

Indexed as

CD79Bcervical cancerprognosistumor-infiltrating immune cellstumor microenvironment

Identifiers

PMID36406115
PMCPMC9666757
OpenAlexW4308126634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.